Intra-Cellular Ther (ITCI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Sales | 680,852 | 464,370 | 250,314 | 83,803 | 22,813 |
| Cost of Goods | 56,963 | 33,745 | 20,443 | 8,035 | 1,895 |
| Gross Profit | 623,889 | 430,625 | 229,871 | 75,768 | 20,918 |
| Operating Expenses | 741,573 | 590,751 | 493,940 | 361,491 | 253,041 |
| Operating Income | -116,721 | -159,381 | -263,626 | -285,688 | -231,228 |
| Other Income | 42,518 | 20,343 | 7,376 | 1,568 | 4,236 |
| Pre-tax Income | -74,203 | -139,038 | -256,250 | -284,120 | -226,992 |
| Income Tax | 473 | 636 | 6 | 6 | 14 |
| Net Income Continuous | -74,676 | -139,674 | -256,256 | -284,126 | -227,006 |
| Net Income | $-74,676 | $-139,674 | $-256,256 | $-284,126 | $-227,006 |
| EPS Basic Total Ops | -0.72 | -1.46 | -2.72 | -3.50 | -3.23 |
| EPS Basic Continuous Ops | -0.72 | -1.46 | -2.72 | -3.50 | -3.23 |
| EPS Diluted Total Ops | -0.72 | -1.46 | -2.72 | -3.50 | -3.23 |
| EPS Diluted Continuous Ops | -0.72 | -1.46 | -2.72 | -3.50 | -3.23 |
| EPS Diluted Before Non-Recurring Items | -0.72 | -1.46 | -2.72 | -3.50 | -3.23 |
| EBITDA(a) | $-125,242 | $-167,253 | $-262,523 | $-289,235 | $-231,348 |